Karl Storz

Asensus, Karl Storz partner on surgical robot marketing, development

The Intelligent Surgical Unit powers the Senhance surgical robot system. [Image courtesy of Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it entered into a memorandum of understanding with Karl Storz VentureONE.

Karl Storz VentureOne is a wholly-owned subsidiary of Karl Storz SE, a maker of endoscopes and other medical instruments and devices. The family-owned company closely collaborates with surgeons and healthcare partners around the globe on technologies for minimally invasive procedures.

The agreement between the surgical robot maker and Karl Storz includes plans for marketing and development. Research Triangle Park, North Carolina-based Asensus develops the Senhance surgical robot platform. It also develops the Intelligent Surgical Unit (ISU) for Senhance.

Asensus designed ISU as a real-time intraoperative surgical image analytics platform. It leverages augmented intelligence to help reduce surgical variability. Earlier this week,…

FDA flags infection risk from reusable urological endoscopes

The FDA said today that is looking into the causes of infections from reprocessed urological endoscopes based on “numerous” adverse event reports.

The agency said that since 2017 it has received more than 450 medical device reports — including three deaths — associated with reprocessed cystoscopes, ureteroscopes and cystourethroscopes used for viewing and accessing the urinary tract. The reports describe post-procedure infections or “other possible contamination issues” associated with cleaning and disinfecting the devices.

Get the full story on our sister site, Medical Design & Outsourcing.